HI
TECH icon

Horizon Investments’s Bio-Techne TECH Stock Holding History

Horizon Investments’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$189K Sell
2,678
-12
-0.4% -$648 ﹤0.01% 1023
2026
Q1 		$141K Buy
2,690
+167
+7% +$10K ﹤0.01% 1037
2025
Q4 		$148K Buy
2,523
+59
+2% +$3.58K ﹤0.01% 1011
2025
Q3 		$137K Sell
2,464
-100
-4% -$5.36K ﹤0.01% 952
2025
Q2 		$132K Buy
2,564
+239
+10% +$12K ﹤0.01% 924
2025
Q1 		$136K Buy
2,325
+169
+8% +$11.5K ﹤0.01% 594
2024
Q4 		$155K Buy
2,156
+18
+0.8% +$1.32K ﹤0.01% 575
2024
Q3 		$171K Sell
2,138
-706
-25% -$53.1K ﹤0.01% 567
2024
Q2 		$204K Buy
2,844
+347
+14% +$25.5K 0.01% 541
2024
Q1 		$176K Sell
2,497
-44
-2% -$3.15K ﹤0.01% 564
2023
Q4 		$196K Buy
2,541
+141
+6% +$9.29K 0.01% 529
2023
Q3 		$163K Buy
2,400
+29
+1% +$2.29K 0.01% 551
2023
Q2 		$194K Buy
2,371
+223
+10% +$17.9K 0.01% 522
2023
Q1 		$159K Sell
2,148
-680
-24% -$52.4K ﹤0.01% 559
2022
Q4 		$234K Buy
+2,828
New +$225K 0.01% 502

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Horizon Investments's TECH Position: Q2 2026 in Review

Horizon Investments reduced its Bio-Techne (TECH) stake by 0.45% in Q2 2026, selling an estimated $648 and leaving 2,678 shares worth $189K. The position accounts for ﹤0.01% of the portfolio, ranked #1023.

Horizon Investments first reported a position in TECH in Q4 2022 and has held it in 15 quarters since. The position peaked at $234K in Q4 2022. 597 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Horizon Investments held 2,678 shares of Bio-Techne worth $189K as of Q2 2026.
  • Horizon Investments sold 12 Bio-Techne shares in Q2 2026, an estimated $648.
  • Bio-Techne made up ﹤0.01% of Horizon Investments's portfolio in Q2 2026, its #1023 holding.
  • Horizon Investments first reported a position in Bio-Techne in Q4 2022 and has held it in 15 quarters since.
  • Horizon Investments's Bio-Techne position peaked at $234K in Q4 2022.
  • 597 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.